Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: Gepirone hcl, Travivo, Gepirone hydrochloride [usan], 83928-66-9, Tgfk07ad, Bmy 13805-1
Molecular Formula
C19H30ClN5O2
Molecular Weight
395.9  g/mol
InChI Key
DGOCVISYYYQFEP-UHFFFAOYSA-N
FDA UNII
80C9L8EP6V

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4,4-dimethyl-1-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]piperidine-2,6-dione;hydrochloride
2.1.2 InChI
InChI=1S/C19H29N5O2.ClH/c1-19(2)14-16(25)24(17(26)15-19)9-4-3-8-22-10-12-23(13-11-22)18-20-6-5-7-21-18;/h5-7H,3-4,8-15H2,1-2H3;1H
2.1.3 InChI Key
DGOCVISYYYQFEP-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1(CC(=O)N(C(=O)C1)CCCCN2CCN(CC2)C3=NC=CC=N3)C.Cl
2.2 Other Identifiers
2.2.1 UNII
80C9L8EP6V
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4,4-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-2,6-piperidinedione

2. Bmy 13805

3. Bmy-13805

4. Gepirone

5. Gepirone Monohydrochloride

6. Mj 13805

7. Mj 13805-1

8. Mj-13805

2.3.2 Depositor-Supplied Synonyms

1. Gepirone Hcl

2. Travivo

3. Gepirone Hydrochloride [usan]

4. 83928-66-9

5. Tgfk07ad

6. Bmy 13805-1

7. 80c9l8ep6v

8. Chembl1204187

9. Variza

10. Ariza

11. Bmy-13805-1

12. Gepirone Er

13. 3,3-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)glutarimide Monohydrochloride

14. Gepirone Hydrochloride (usan)

15. 2,6-piperidinedione, 4,4-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, Monohydrochloride

16. Bmy-13805

17. Unii-80c9l8ep6v

18. Bmy 138951

19. Schembl318838

20. Dtxsid30232812

21. Org-33062

22. Gepirone Hydrochloride [mart.]

23. Gepirone Hydrochloride [who-dd]

24. Sb19633

25. Mj-13805

26. D04314

27. Q27269140

28. 2,6-piperidinedione, 4,4-dimethyl-1-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, Hydrochloride (1:1)

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 395.9 g/mol
Molecular Formula C19H30ClN5O2
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count6
Exact Mass395.2088029 g/mol
Monoisotopic Mass395.2088029 g/mol
Topological Polar Surface Area69.6 Ų
Heavy Atom Count27
Formal Charge0
Complexity476
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Anxiety Agents

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)


Antidepressive Agents

Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)


Serotonin Receptor Agonists

Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)